nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Induration—Bleomycin—melanoma	0.0204	0.0408	CcSEcCtD
Pentazocine—Grand mal convulsion—Carmustine—melanoma	0.0167	0.0335	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00983	0.0197	CcSEcCtD
Pentazocine—Ulcer—Bleomycin—melanoma	0.00963	0.0193	CcSEcCtD
Pentazocine—Eosinophilia—Vemurafenib—melanoma	0.00934	0.0187	CcSEcCtD
Pentazocine—Ulcer—Dactinomycin—melanoma	0.00898	0.018	CcSEcCtD
Pentazocine—Disorientation—Bleomycin—melanoma	0.00739	0.0148	CcSEcCtD
Pentazocine—Erythema multiforme—Vemurafenib—melanoma	0.00714	0.0143	CcSEcCtD
Pentazocine—Chills—Vemurafenib—melanoma	0.00678	0.0136	CcSEcCtD
Pentazocine—Dysgeusia—Vemurafenib—melanoma	0.00644	0.0129	CcSEcCtD
Pentazocine—Diplopia—Carmustine—melanoma	0.00577	0.0116	CcSEcCtD
Pentazocine—Diplopia—Temozolomide—melanoma	0.00558	0.0112	CcSEcCtD
Pentazocine—Face oedema—Carmustine—melanoma	0.00557	0.0112	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00555	0.0111	CcSEcCtD
Pentazocine—Face oedema—Temozolomide—melanoma	0.00539	0.0108	CcSEcCtD
Pentazocine—Anaphylactic shock—Vemurafenib—melanoma	0.00536	0.0108	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00502	0.0101	CcSEcCtD
Pentazocine—Hypotension—Vemurafenib—melanoma	0.00501	0.01	CcSEcCtD
Pentazocine—Sweating increased—Temozolomide—melanoma	0.0047	0.00941	CcSEcCtD
Pentazocine—Decreased appetite—Vemurafenib—melanoma	0.00466	0.00934	CcSEcCtD
Pentazocine—Constipation—Vemurafenib—melanoma	0.00459	0.00919	CcSEcCtD
Pentazocine—Lightheadedness—Docetaxel—melanoma	0.00457	0.00916	CcSEcCtD
Pentazocine—Agranulocytosis—Dactinomycin—melanoma	0.00444	0.00889	CcSEcCtD
Pentazocine—Flushing—Bleomycin—melanoma	0.00425	0.00851	CcSEcCtD
Pentazocine—Chills—Bleomycin—melanoma	0.0041	0.00823	CcSEcCtD
Pentazocine—Erythema multiforme—Dactinomycin—melanoma	0.00403	0.00808	CcSEcCtD
Pentazocine—Hallucination—Carmustine—melanoma	0.00397	0.00796	CcSEcCtD
Pentazocine—Flushing—Dactinomycin—melanoma	0.00396	0.00793	CcSEcCtD
Pentazocine—Hypersensitivity—Vemurafenib—melanoma	0.00395	0.00792	CcSEcCtD
Pentazocine—Visual disturbance—Docetaxel—melanoma	0.00391	0.00784	CcSEcCtD
Pentazocine—Asthenia—Vemurafenib—melanoma	0.00385	0.00771	CcSEcCtD
Pentazocine—Visual impairment—Carmustine—melanoma	0.00385	0.00771	CcSEcCtD
Pentazocine—Hallucination—Temozolomide—melanoma	0.00384	0.00769	CcSEcCtD
Pentazocine—Chills—Dactinomycin—melanoma	0.00383	0.00767	CcSEcCtD
Pentazocine—Pruritus—Vemurafenib—melanoma	0.0038	0.00761	CcSEcCtD
Pentazocine—Visual impairment—Temozolomide—melanoma	0.00372	0.00745	CcSEcCtD
Pentazocine—Flushing—Carmustine—melanoma	0.00371	0.00743	CcSEcCtD
Pentazocine—Diarrhoea—Vemurafenib—melanoma	0.00367	0.00736	CcSEcCtD
Pentazocine—Erythema multiforme—Temozolomide—melanoma	0.00365	0.00731	CcSEcCtD
Pentazocine—Tinnitus—Temozolomide—melanoma	0.0036	0.00721	CcSEcCtD
Pentazocine—Flushing—Temozolomide—melanoma	0.00358	0.00718	CcSEcCtD
Pentazocine—Dizziness—Vemurafenib—melanoma	0.00355	0.00711	CcSEcCtD
Pentazocine—Chills—Temozolomide—melanoma	0.00346	0.00694	CcSEcCtD
Pentazocine—Vomiting—Vemurafenib—melanoma	0.00341	0.00684	CcSEcCtD
Pentazocine—Dermatitis—Vemurafenib—melanoma	0.00338	0.00677	CcSEcCtD
Pentazocine—Headache—Vemurafenib—melanoma	0.00336	0.00673	CcSEcCtD
Pentazocine—Cramp muscle—Docetaxel—melanoma	0.00334	0.00669	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00334	0.00669	CcSEcCtD
Pentazocine—Dysgeusia—Temozolomide—melanoma	0.00329	0.00659	CcSEcCtD
Pentazocine—Confusional state—Bleomycin—melanoma	0.00328	0.00657	CcSEcCtD
Pentazocine—Vision blurred—Carmustine—melanoma	0.00328	0.00656	CcSEcCtD
Pentazocine—Tremor—Carmustine—melanoma	0.00326	0.00653	CcSEcCtD
Pentazocine—Anaphylactic shock—Bleomycin—melanoma	0.00325	0.00651	CcSEcCtD
Pentazocine—Agitation—Carmustine—melanoma	0.00319	0.0064	CcSEcCtD
Pentazocine—Nausea—Vemurafenib—melanoma	0.00319	0.00639	CcSEcCtD
Pentazocine—Vision blurred—Temozolomide—melanoma	0.00317	0.00634	CcSEcCtD
Pentazocine—Tremor—Temozolomide—melanoma	0.00315	0.00631	CcSEcCtD
Pentazocine—Anorexia—Bleomycin—melanoma	0.0031	0.00621	CcSEcCtD
Pentazocine—Agitation—Temozolomide—melanoma	0.00309	0.00619	CcSEcCtD
Pentazocine—Hypotension—Bleomycin—melanoma	0.00304	0.00609	CcSEcCtD
Pentazocine—Vertigo—Temozolomide—melanoma	0.00302	0.00605	CcSEcCtD
Pentazocine—Hypertension—Carmustine—melanoma	0.003	0.00601	CcSEcCtD
Pentazocine—Paraesthesia—Bleomycin—melanoma	0.00292	0.00585	CcSEcCtD
Pentazocine—Hypertension—Temozolomide—melanoma	0.0029	0.00581	CcSEcCtD
Pentazocine—Dyspnoea—Bleomycin—melanoma	0.0029	0.00581	CcSEcCtD
Pentazocine—Anorexia—Dactinomycin—melanoma	0.00289	0.00579	CcSEcCtD
Pentazocine—Confusional state—Carmustine—melanoma	0.00286	0.00573	CcSEcCtD
Pentazocine—Decreased appetite—Bleomycin—melanoma	0.00283	0.00566	CcSEcCtD
Pentazocine—Dry mouth—Temozolomide—melanoma	0.0028	0.00561	CcSEcCtD
Pentazocine—Tachycardia—Carmustine—melanoma	0.00277	0.00555	CcSEcCtD
Pentazocine—Confusional state—Temozolomide—melanoma	0.00276	0.00554	CcSEcCtD
Pentazocine—Anaphylactic shock—Temozolomide—melanoma	0.00274	0.00549	CcSEcCtD
Pentazocine—Anorexia—Carmustine—melanoma	0.0027	0.00542	CcSEcCtD
Pentazocine—Feeling abnormal—Bleomycin—melanoma	0.00268	0.00537	CcSEcCtD
Pentazocine—Agranulocytosis—Docetaxel—melanoma	0.00267	0.00535	CcSEcCtD
Pentazocine—Hypotension—Carmustine—melanoma	0.00265	0.00531	CcSEcCtD
Pentazocine—Hyperhidrosis—Temozolomide—melanoma	0.00265	0.00531	CcSEcCtD
Pentazocine—Decreased appetite—Dactinomycin—melanoma	0.00264	0.00528	CcSEcCtD
Pentazocine—Anorexia—Temozolomide—melanoma	0.00261	0.00524	CcSEcCtD
Pentazocine—Insomnia—Carmustine—melanoma	0.00257	0.00514	CcSEcCtD
Pentazocine—Paraesthesia—Carmustine—melanoma	0.00255	0.0051	CcSEcCtD
Pentazocine—Dyspnoea—Carmustine—melanoma	0.00253	0.00507	CcSEcCtD
Pentazocine—Somnolence—Carmustine—melanoma	0.00252	0.00505	CcSEcCtD
Pentazocine—Feeling abnormal—Dactinomycin—melanoma	0.0025	0.00501	CcSEcCtD
Pentazocine—Insomnia—Temozolomide—melanoma	0.00248	0.00497	CcSEcCtD
Pentazocine—Visual impairment—Docetaxel—melanoma	0.00247	0.00496	CcSEcCtD
Pentazocine—Decreased appetite—Carmustine—melanoma	0.00247	0.00494	CcSEcCtD
Pentazocine—Paraesthesia—Temozolomide—melanoma	0.00246	0.00493	CcSEcCtD
Pentazocine—Dyspnoea—Temozolomide—melanoma	0.00244	0.0049	CcSEcCtD
Pentazocine—Somnolence—Temozolomide—melanoma	0.00244	0.00488	CcSEcCtD
Pentazocine—Erythema multiforme—Docetaxel—melanoma	0.00243	0.00486	CcSEcCtD
Pentazocine—Constipation—Carmustine—melanoma	0.00243	0.00486	CcSEcCtD
Pentazocine—Hypersensitivity—Bleomycin—melanoma	0.00239	0.0048	CcSEcCtD
Pentazocine—Decreased appetite—Temozolomide—melanoma	0.00238	0.00478	CcSEcCtD
Pentazocine—Flushing—Docetaxel—melanoma	0.00238	0.00477	CcSEcCtD
Pentazocine—Constipation—Temozolomide—melanoma	0.00234	0.0047	CcSEcCtD
Pentazocine—Feeling abnormal—Carmustine—melanoma	0.00234	0.00468	CcSEcCtD
Pentazocine—Asthenia—Bleomycin—melanoma	0.00233	0.00467	CcSEcCtD
Pentazocine—Chills—Docetaxel—melanoma	0.0023	0.00461	CcSEcCtD
Pentazocine—Pruritus—Bleomycin—melanoma	0.0023	0.00461	CcSEcCtD
Pentazocine—Feeling abnormal—Temozolomide—melanoma	0.00226	0.00453	CcSEcCtD
Pentazocine—Hypersensitivity—Dactinomycin—melanoma	0.00223	0.00448	CcSEcCtD
Pentazocine—Dysgeusia—Docetaxel—melanoma	0.00219	0.00438	CcSEcCtD
Pentazocine—Asthenia—Dactinomycin—melanoma	0.00217	0.00436	CcSEcCtD
Pentazocine—Muscle spasms—Docetaxel—melanoma	0.00215	0.0043	CcSEcCtD
Pentazocine—Hypersensitivity—Carmustine—melanoma	0.00209	0.00419	CcSEcCtD
Pentazocine—Diarrhoea—Dactinomycin—melanoma	0.00207	0.00416	CcSEcCtD
Pentazocine—Vomiting—Bleomycin—melanoma	0.00207	0.00414	CcSEcCtD
Pentazocine—Dermatitis—Bleomycin—melanoma	0.00205	0.0041	CcSEcCtD
Pentazocine—Asthenia—Carmustine—melanoma	0.00204	0.00408	CcSEcCtD
Pentazocine—Hypersensitivity—Temozolomide—melanoma	0.00202	0.00405	CcSEcCtD
Pentazocine—Syncope—Docetaxel—melanoma	0.002	0.00401	CcSEcCtD
Pentazocine—Asthenia—Temozolomide—melanoma	0.00197	0.00394	CcSEcCtD
Pentazocine—Loss of consciousness—Docetaxel—melanoma	0.00196	0.00393	CcSEcCtD
Pentazocine—Diarrhoea—Carmustine—melanoma	0.00194	0.00389	CcSEcCtD
Pentazocine—Pruritus—Temozolomide—melanoma	0.00194	0.00389	CcSEcCtD
Pentazocine—Nausea—Bleomycin—melanoma	0.00193	0.00387	CcSEcCtD
Pentazocine—Hypertension—Docetaxel—melanoma	0.00193	0.00387	CcSEcCtD
Pentazocine—Vomiting—Dactinomycin—melanoma	0.00193	0.00386	CcSEcCtD
Pentazocine—Dizziness—Carmustine—melanoma	0.00188	0.00376	CcSEcCtD
Pentazocine—Diarrhoea—Temozolomide—melanoma	0.00188	0.00376	CcSEcCtD
Pentazocine—Dry mouth—Docetaxel—melanoma	0.00186	0.00373	CcSEcCtD
Pentazocine—Confusional state—Docetaxel—melanoma	0.00184	0.00368	CcSEcCtD
Pentazocine—Anaphylactic shock—Docetaxel—melanoma	0.00182	0.00365	CcSEcCtD
Pentazocine—Dizziness—Temozolomide—melanoma	0.00181	0.00363	CcSEcCtD
Pentazocine—Vomiting—Carmustine—melanoma	0.0018	0.00361	CcSEcCtD
Pentazocine—Nausea—Dactinomycin—melanoma	0.0018	0.00361	CcSEcCtD
Pentazocine—Shock—Docetaxel—melanoma	0.00179	0.00359	CcSEcCtD
Pentazocine—Dermatitis—Carmustine—melanoma	0.00179	0.00358	CcSEcCtD
Pentazocine—Tachycardia—Docetaxel—melanoma	0.00178	0.00357	CcSEcCtD
Pentazocine—Headache—Carmustine—melanoma	0.00178	0.00356	CcSEcCtD
Pentazocine—Vomiting—Temozolomide—melanoma	0.00174	0.00349	CcSEcCtD
Pentazocine—Anorexia—Docetaxel—melanoma	0.00174	0.00348	CcSEcCtD
Pentazocine—Dermatitis—Temozolomide—melanoma	0.00173	0.00346	CcSEcCtD
Pentazocine—Headache—Temozolomide—melanoma	0.00172	0.00344	CcSEcCtD
Pentazocine—Hypotension—Docetaxel—melanoma	0.0017	0.00341	CcSEcCtD
Pentazocine—Nausea—Carmustine—melanoma	0.00169	0.00338	CcSEcCtD
Pentazocine—Insomnia—Docetaxel—melanoma	0.00165	0.0033	CcSEcCtD
Pentazocine—Paraesthesia—Docetaxel—melanoma	0.00164	0.00328	CcSEcCtD
Pentazocine—Nausea—Temozolomide—melanoma	0.00163	0.00326	CcSEcCtD
Pentazocine—Dyspnoea—Docetaxel—melanoma	0.00163	0.00326	CcSEcCtD
Pentazocine—Somnolence—Docetaxel—melanoma	0.00162	0.00325	CcSEcCtD
Pentazocine—Decreased appetite—Docetaxel—melanoma	0.00159	0.00318	CcSEcCtD
Pentazocine—Constipation—Docetaxel—melanoma	0.00156	0.00312	CcSEcCtD
Pentazocine—Feeling abnormal—Docetaxel—melanoma	0.0015	0.00301	CcSEcCtD
Pentazocine—Hypersensitivity—Docetaxel—melanoma	0.00134	0.00269	CcSEcCtD
Pentazocine—Asthenia—Docetaxel—melanoma	0.00131	0.00262	CcSEcCtD
Pentazocine—Pruritus—Docetaxel—melanoma	0.00129	0.00258	CcSEcCtD
Pentazocine—Diarrhoea—Docetaxel—melanoma	0.00125	0.0025	CcSEcCtD
Pentazocine—Dizziness—Docetaxel—melanoma	0.00121	0.00242	CcSEcCtD
Pentazocine—Vomiting—Docetaxel—melanoma	0.00116	0.00232	CcSEcCtD
Pentazocine—Dermatitis—Docetaxel—melanoma	0.00115	0.0023	CcSEcCtD
Pentazocine—Headache—Docetaxel—melanoma	0.00114	0.00229	CcSEcCtD
Pentazocine—Nausea—Docetaxel—melanoma	0.00108	0.00217	CcSEcCtD
Pentazocine—OPRD1—Signaling Pathways—SOCS1—melanoma	0.000171	0.000341	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAP2K1—melanoma	0.000171	0.00034	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—S100B—melanoma	0.00017	0.00034	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CD—melanoma	0.000169	0.000338	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RAC1—melanoma	0.000169	0.000337	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—melanoma	0.000169	0.000337	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDNRB—melanoma	0.000169	0.000337	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SYK—melanoma	0.000165	0.000329	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTK2B—melanoma	0.000164	0.000327	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CD—melanoma	0.000164	0.000327	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB4—melanoma	0.000163	0.000325	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—melanoma	0.000163	0.000325	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CB—melanoma	0.000163	0.000325	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGAV—melanoma	0.000162	0.000323	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT3—melanoma	0.000162	0.000323	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGFR—melanoma	0.000162	0.000323	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN2B—melanoma	0.000162	0.000323	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAB2—melanoma	0.000159	0.000318	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNA11—melanoma	0.000159	0.000318	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FLT1—melanoma	0.000159	0.000317	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	0.000157	0.000314	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD86—melanoma	0.000156	0.000312	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—melanoma	0.000156	0.000312	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDN1—melanoma	0.000155	0.00031	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CSF2—melanoma	0.000152	0.000303	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF1—melanoma	0.000152	0.000303	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HDAC2—melanoma	0.00015	0.000299	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FOXO4—melanoma	0.00015	0.000299	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCR4—melanoma	0.00015	0.000299	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS1—melanoma	0.00015	0.000299	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAP2K1—melanoma	0.00015	0.000298	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—S100B—melanoma	0.000149	0.000298	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—melanoma	0.000149	0.000298	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—melanoma	0.000149	0.000296	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—E2F1—melanoma	0.000148	0.000296	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNAQ—melanoma	0.000148	0.000296	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—melanoma	0.000148	0.000295	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFRA—melanoma	0.000147	0.000293	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITGB3—melanoma	0.000145	0.00029	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCA—melanoma	0.000145	0.00029	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB4—melanoma	0.000143	0.000285	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—melanoma	0.000143	0.000285	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—melanoma	0.000143	0.000285	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SPP1—melanoma	0.000143	0.000284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP2K2—melanoma	0.000142	0.000284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—melanoma	0.000142	0.000283	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN2B—melanoma	0.000142	0.000283	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SYK—melanoma	0.000139	0.000278	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	0.000138	0.000276	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD86—melanoma	0.000137	0.000274	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—melanoma	0.000137	0.000273	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGAV—melanoma	0.000137	0.000273	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT3—melanoma	0.000137	0.000273	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGFR—melanoma	0.000137	0.000273	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDN1—melanoma	0.000136	0.000271	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—melanoma	0.000136	0.000271	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TERT—melanoma	0.000135	0.00027	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RAC1—melanoma	0.000135	0.000269	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—melanoma	0.000133	0.000266	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CSF2—melanoma	0.000133	0.000265	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF1—melanoma	0.000133	0.000265	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—melanoma	0.000131	0.000261	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—E2F1—melanoma	0.00013	0.00026	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—melanoma	0.000129	0.000258	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—melanoma	0.000129	0.000258	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFRA—melanoma	0.000129	0.000257	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGB3—melanoma	0.000127	0.000254	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCA—melanoma	0.000127	0.000254	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS1—melanoma	0.000127	0.000253	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAP2K1—melanoma	0.000126	0.000252	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—S100B—melanoma	0.000126	0.000252	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—melanoma	0.000126	0.000251	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SPP1—melanoma	0.000125	0.000249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP2K2—melanoma	0.000125	0.000249	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—melanoma	0.000124	0.000248	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—melanoma	0.000124	0.000247	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB4—melanoma	0.000121	0.000241	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	0.00012	0.000241	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN2B—melanoma	0.00012	0.000239	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FN1—melanoma	0.000119	0.000237	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—melanoma	0.000119	0.000237	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TERT—melanoma	0.000118	0.000236	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RAC1—melanoma	0.000118	0.000236	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH1—melanoma	0.000116	0.000232	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD86—melanoma	0.000116	0.000231	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—melanoma	0.000116	0.000231	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDN1—melanoma	0.000115	0.000229	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD80—melanoma	0.000114	0.000228	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—melanoma	0.000114	0.000227	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APC—melanoma	0.000114	0.000227	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KIT—melanoma	0.000114	0.000227	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NRAS—melanoma	0.000114	0.000227	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—melanoma	0.000113	0.000226	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGF—melanoma	0.000113	0.000225	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF1—melanoma	0.000112	0.000224	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CSF2—melanoma	0.000112	0.000224	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—melanoma	0.000111	0.000221	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—E2F1—melanoma	0.00011	0.000219	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—melanoma	0.000109	0.000218	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK3—melanoma	0.000109	0.000218	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFRA—melanoma	0.000109	0.000217	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—melanoma	0.000108	0.000216	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGB3—melanoma	0.000108	0.000215	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCA—melanoma	0.000108	0.000215	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BRAF—melanoma	0.000107	0.000214	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SPP1—melanoma	0.000106	0.000211	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP2K2—melanoma	0.000105	0.00021	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—melanoma	0.000105	0.00021	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FN1—melanoma	0.000104	0.000208	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—melanoma	0.000104	0.000208	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK1—melanoma	0.000104	0.000207	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—melanoma	0.000104	0.000207	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH1—melanoma	0.000102	0.000204	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP2K1—melanoma	0.000101	0.000201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—melanoma	0.0001	0.000201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TERT—melanoma	0.0001	0.0002	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—melanoma	0.0001	0.0002	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD80—melanoma	0.0001	0.0002	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RAC1—melanoma	9.98e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KIT—melanoma	9.98e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APC—melanoma	9.98e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—melanoma	9.98e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NRAS—melanoma	9.98e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	9.91e-05	0.000198	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGF—melanoma	9.87e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—melanoma	9.8e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—melanoma	9.58e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—melanoma	9.57e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK3—melanoma	9.56e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BRAF—melanoma	9.38e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—melanoma	9.16e-05	0.000183	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—melanoma	9.14e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK1—melanoma	9.1e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—melanoma	9.09e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—melanoma	9e-05	0.00018	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MDM2—melanoma	8.96e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB2—melanoma	8.84e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP2K1—melanoma	8.83e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FN1—melanoma	8.81e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—melanoma	8.77e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—melanoma	8.72e-05	0.000174	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	8.69e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH1—melanoma	8.63e-05	0.000172	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—melanoma	8.59e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD80—melanoma	8.45e-05	0.000169	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KIT—melanoma	8.44e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APC—melanoma	8.44e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—melanoma	8.44e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NRAS—melanoma	8.44e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—melanoma	8.4e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—melanoma	8.38e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGF—melanoma	8.34e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRAS—melanoma	8.33e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1B—melanoma	8.19e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—melanoma	8.1e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK3—melanoma	8.08e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—melanoma	8.02e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—melanoma	8.01e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—melanoma	7.97e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BRAF—melanoma	7.93e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—melanoma	7.89e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MDM2—melanoma	7.86e-05	0.000157	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—melanoma	7.81e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB2—melanoma	7.75e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CTNNB1—melanoma	7.73e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—melanoma	7.72e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK1—melanoma	7.69e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—melanoma	7.69e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—melanoma	7.65e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—melanoma	7.58e-05	0.000151	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—melanoma	7.55e-05	0.000151	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—melanoma	7.54e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKB1—melanoma	7.5e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP2K1—melanoma	7.46e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—melanoma	7.42e-05	0.000148	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—melanoma	7.35e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—melanoma	7.35e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	7.35e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRAS—melanoma	7.3e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—melanoma	7.26e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1B—melanoma	7.18e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—melanoma	7.1e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—melanoma	7.1e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—melanoma	7.03e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—melanoma	7.02e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—melanoma	6.99e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—melanoma	6.85e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—melanoma	6.81e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CTNNB1—melanoma	6.78e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—melanoma	6.74e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NRAS—melanoma	6.72e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	6.67e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—melanoma	6.65e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MDM2—melanoma	6.64e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—melanoma	6.62e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—melanoma	6.61e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKB1—melanoma	6.58e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB2—melanoma	6.55e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—melanoma	6.46e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—melanoma	6.45e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK3—melanoma	6.44e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—melanoma	6.26e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—melanoma	6.21e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRAS—melanoma	6.17e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK1—melanoma	6.13e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—melanoma	6.13e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1B—melanoma	6.07e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—melanoma	6e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—melanoma	5.97e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—melanoma	5.95e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—melanoma	5.94e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—melanoma	5.91e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—melanoma	5.91e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRAS—melanoma	5.9e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—melanoma	5.79e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—melanoma	5.79e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CTNNB1—melanoma	5.73e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK3—melanoma	5.65e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—melanoma	5.62e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—melanoma	5.6e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—melanoma	5.59e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKB1—melanoma	5.56e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—melanoma	5.49e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—melanoma	5.45e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK1—melanoma	5.37e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—melanoma	5.37e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—melanoma	5.32e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—melanoma	5.14e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—melanoma	5.07e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—melanoma	5.04e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—melanoma	5e-05	9.97e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRAS—melanoma	4.98e-05	9.95e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRAS—melanoma	4.92e-05	9.82e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK3—melanoma	4.77e-05	9.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—melanoma	4.71e-05	9.4e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—melanoma	4.66e-05	9.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—melanoma	4.64e-05	9.27e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK1—melanoma	4.54e-05	9.06e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—melanoma	4.54e-05	9.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—melanoma	4.51e-05	9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—melanoma	4.34e-05	8.67e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRAS—melanoma	4.31e-05	8.61e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—melanoma	4.29e-05	8.56e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—melanoma	4.13e-05	8.24e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—melanoma	3.94e-05	7.87e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—melanoma	3.81e-05	7.61e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—melanoma	3.81e-05	7.6e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRAS—melanoma	3.65e-05	7.28e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—melanoma	3.49e-05	6.96e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—melanoma	3.22e-05	6.43e-05	CbGpPWpGaD
